William Blair initiated coverage of Inari Medical with an Outperform rating.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NARI:
- Inari Medical downgraded to Hold from Buy at Needham
- Inari Medical price target raised to $60 from $47 at Truist
- Inari Medical price target raised to $60 from $55 at Morgan Stanley
- Piper says Sight Sciences, Paragon 28 codes rated higher in CMS proposal
- Class Action Lawsuit Against Inari Medical, Inc. (NASDAQ:NARI)